{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T12:06:40Z","timestamp":1711368400426},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2020,9,5]],"date-time":"2020-09-05T00:00:00Z","timestamp":1599264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,10,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Failure mode critical effect analysis and design of experiment-based high performance thin layer chromatography (HPTLC) method has been developed for simultaneous estimation of lornoxicam (LOC) and eperisone hydrochloride (EPR). Failure modes were identified on the basis of prior knowledge and experimental data with the help of Ishikawa diagram for the development of method. The criticality of failure mode was assessed by giving risk priority number and criticality rank on the basis of preliminary experimental trials. The identified critical failure modes were analyzed for their effect by design of experiment (DoE)-based Plackett\u2013Burman screening design. From 11 critical factors, the volume of methanol and modifier in mobile phase composition were found as critical failure modes. Critical failure mode was further analyzed by DoE based on central composite design for study of their relationship with resolution of both drugs. Quadratic model suggested by design was further used for failure mode risk control and navigation of design space for a resolution of both drugs more than 1.5. Failure mode risk control strategy was set for robust HPTLC method for simultaneous estimation of both drugs in laboratory mixture. Developed and validated HPTLC method was applied for assay of LOC and EPR in their laboratory mixture and assay values were found in good agreement with a spiked amount of drugs.<\/jats:p>","DOI":"10.1093\/chromsci\/bmaa064","type":"journal-article","created":{"date-parts":[[2020,9,5]],"date-time":"2020-09-05T02:13:13Z","timestamp":1599271993000},"page":"929-939","source":"Crossref","is-referenced-by-count":18,"title":["Failure Mode Critical Effect Analysis and Design of Experiment-Based Robust Chromatographic Method for Simultaneous Estimation Lornoxicam and Eperisone Hydrochloride"],"prefix":"10.1093","volume":"58","author":[{"given":"Pintu","family":"Prajapati","sequence":"first","affiliation":[{"name":"Department of Quality Assurance, Maliba Pharmacy College, Uka Tarsadia University, Maliba Campus, Bardoli-mahuva road, Tarsadi, Mahuva, Surat-394 350, Gujarat, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vipul","family":"Radadiya","sequence":"additional","affiliation":[{"name":"Department of Quality Assurance, Maliba Pharmacy College, Uka Tarsadia University, Maliba Campus, Bardoli-mahuva road, Tarsadi, Mahuva, Surat-394 350, Gujarat, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shailesh","family":"Shah","sequence":"additional","affiliation":[{"name":"Department of Quality Assurance, Maliba Pharmacy College, Uka Tarsadia University, Maliba Campus, Bardoli-mahuva road, Tarsadi, Mahuva, Surat-394 350, Gujarat, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,9,5]]},"reference":[{"key":"2020102600504107900_ref1","article-title":"Introduction of Muscle Spasms","author":"Christensen"},{"key":"2020102600504107900_ref2","article-title":"Drugs for Muscle Relaxants","author":"Hardning"},{"key":"2020102600504107900_ref3","article-title":"List of Approved Drug"},{"key":"2020102600504107900_ref4","volume-title":"Pharmaceutical Product Development Q8R2 International Conference on Harmonization","year":"2009"},{"key":"2020102600504107900_ref5","volume-title":"Quality Risk Management Q9 International Conference on Harmonization","year":"2005"},{"issue":"4","key":"2020102600504107900_ref6","first-page":"139","article-title":"Development and validation of lornoxicam by second order derivative spectroscopy","volume":"3","author":"Khan","year":"2011","journal-title":"International Journal of Pharmacy and Pharmaceutical Sciences"},{"issue":"4","key":"2020102600504107900_ref7","first-page":"1666","article-title":"UV-spectrophotometric method for simultaneous estimation of lornoxicam and eperisone hydrochloride in bulk drug, formulations and aqueous dissolution samples","volume":"11","author":"Prasad","year":"2020","journal-title":"International Journal of Pharmaceutical Sciences and Research"},{"issue":"3","key":"2020102600504107900_ref8","first-page":"960","article-title":"Development and validation of stability indicating RP-HPLC method for lornoxicam in bulk drug","volume":"4","author":"Bhatt","year":"2013","journal-title":"International Journal of Research in Pharmaceutical and Biomedical Sciences"},{"issue":"1","key":"2020102600504107900_ref9","first-page":"468","article-title":"Development and validation of a stability indicating assay method of lornoxicam by using UV-visible spectrophotometer","volume":"2","author":"Tapkir","year":"2013","journal-title":"International Journal of Pharmaceutical and Chemical Sciences"},{"issue":"2","key":"2020102600504107900_ref10","first-page":"398","article-title":"Spectrophotometric determination of eperisone and lornoxicamin synthetic mixture","volume":"5","author":"Palak","year":"2013","journal-title":"International Journal of PharmTech Research"},{"issue":"4","key":"2020102600504107900_ref11","first-page":"372","article-title":"Development and validation of RP-HPLC method for simultaneous estimation of eperisone hydrochloride and lornoxicam in a synthetic mixture","volume":"6","author":"Sejal","year":"2013","journal-title":"Asian Journal of Research in Chemistry"},{"issue":"2","key":"2020102600504107900_ref12","first-page":"88","article-title":"Method development and validation of RP-HPLC method for simultaneous estimation of paracetamol and eperisone hydrochloride in pharmaceutical dosage forms","volume":"1","author":"Venkata","year":"2013","journal-title":"PharmaTutor"},{"issue":"2","key":"2020102600504107900_ref13","first-page":"1","article-title":"Development and validation of RP-HPLC methods for simultaneous estimation of eperisone hydrochloride and lornoxicam in bulk and their synthetic","volume":"2","author":"Patel","year":"2013","journal-title":"Inventi Rapid"},{"issue":"1","key":"2020102600504107900_ref14","first-page":"6","article-title":"HPLC method development and validation for estimation of eperisone hydrochloride from bulk and marketed formulation","volume":"9","author":"Kumbhar","year":"2019","journal-title":"International Journal of Pharmacy Research & Technology"},{"key":"2020102600504107900_ref15","volume-title":"Validation of Analytical Procedures: Text and Methodology Q2 (R1), International Conference on Harmonization","year":"2005"}],"container-title":["Journal of Chromatographic Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/chromsci\/article-pdf\/58\/10\/929\/34002670\/bmaa064.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/chromsci\/article-pdf\/58\/10\/929\/34002670\/bmaa064.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,26]],"date-time":"2020-10-26T04:50:49Z","timestamp":1603687849000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/chromsci\/article\/58\/10\/929\/5901555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,5]]},"references-count":15,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,9,5]]},"published-print":{"date-parts":[[2020,10,26]]}},"URL":"https:\/\/doi.org\/10.1093\/chromsci\/bmaa064","relation":{},"ISSN":["0021-9665","1945-239X"],"issn-type":[{"value":"0021-9665","type":"print"},{"value":"1945-239X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,11]]},"published":{"date-parts":[[2020,9,5]]}}}